Clinical Trials · NCT02020629

Study on Lixisenatide and Counterregulation to Hypoglycemia

Name: Study on Lixisenatide and Counterregulation to Hypoglycemia
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 4Lixisenatide

Phase: Phase 4
Recruitment status: Completed
Sponsor: Lund University
Enrollment: 18
Start date: Dec 2013
Locations: 1 site, Sweden
Primary endpoint: Glucagon response to hypoglycemia

View Lixisenatide compound reference